1. Home
  2. IE vs ZYME Comparison

IE vs ZYME Comparison

Compare IE & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ivanhoe Electric Inc.

IE

Ivanhoe Electric Inc.

HOLD

Current Price

$11.51

Market Cap

2.1B

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$24.13

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IE
ZYME
Founded
2020
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
IE
ZYME
Price
$11.51
$24.13
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$18.17
$38.90
AVG Volume (30 Days)
1.7M
617.3K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
$3,244,000.00
$105,965,000.00
Revenue This Year
$44.79
$183.10
Revenue Next Year
$16.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.82
38.87
52 Week Low
$7.72
$11.86
52 Week High
$21.55
$29.75

Technical Indicators

Market Signals
Indicator
IE
ZYME
Relative Strength Index (RSI) 39.88 42.91
Support Level $8.53 $22.28
Resistance Level $15.70 $27.81
Average True Range (ATR) 0.87 0.87
MACD -0.03 -0.00
Stochastic Oscillator 2.57 12.93

Price Performance

Historical Comparison
IE
ZYME

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: